EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting WTAP/ROR1/WNT5A‐Mediated Crosstalk Between Glioma Stem Cells and Macrophages to Normalize Tumor Vasculature and Enhance Chemotherapy

Xiaoyong Chen, Bo Pang, Yun Liu, Jiangwei Wang, Lanhui Zheng, Yuzhou Chang, Yingxuan Sun, Haoyuan Sun, Huiyuan Chen, Jiawei Cai, Zanyi Wu, Qing Chang und 4 weitere

Advanced Science · 2026-04 · 13 (21)

DOI: 10.1002/advs.202520661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 21.01.2026. Verfasst von Xiaoyong Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Wnt-5a Protein, Neoplastic Stem Cells, Glioma, Receptor Tyrosine Kinase-like Orphan Receptors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, High-level Talents Research Start-up Project of the First Affiliated Hospital, Fujian Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioma stem cells (GSCs) can trans‐differentiate into glioma‐derived endothelial cells (GDECs), contributing to glioblastoma progression and therapy resistance. The molecular basis underpinning GSC‐GDEC differentiation remain incompletely elucidated. Here, ROR1 is identified as a key regulator of GSC‐to‐GDEC differentiation under hypoxia. ROR1 expression is elevated in GDECs across patient‐derived cells, xenografts, and tumor samples, confirmed by single‐cell multiomics, Western blotting, and multiplex staining. Mechanistically, WNT5A, secreted by tumor‐associated macrophages (TAMs) under hypoxia, activates ROR1‐mediated Wingless‐type MMTV integration site family (WNT) signaling in GSCs, promoting GDEC formation. Interestingly, hypoxia‐induced WTAP not only enhances ROR1 stability through m 6 A modification in a HuR‐dependent manner, but also contributes to WNT5A+TAMs infiltration. Clinically, high ROR1 and WNT5A expression correlates with poor glioblastoma prognosis, and WNT5A may serve as a circulating biomarker. Therapeutically, targeting ROR1 via endothelial‐specific Adno‐Associated Virus (AAV) knockdown or the antibody‐drug conjugate Zilovertamab vedotin (VLS‐101) normalizes vasculature, improves temozolomide delivery, and sensitizes tumors in glioblastoma organoids and xenografts. These findings highlight the ROR1–WNT5A axis as a promising target in glioblastomas treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wnt-5a ProteinNeoplastic Stem CellsGliomaReceptor Tyrosine Kinase-like Orphan ReceptorsRNA Splicing FactorsBrain NeoplasmsMacrophagesNeovascularization, PathologicHumansAnimalsMiceGlioblastomaEndothelial Cells

Stichwörter der Autor:innen

endothelial differentiationglioma stem cellm6Amacrophagetargeted therapy

Substanzen

Wnt-5a ProteinWNT5A protein, humanReceptor Tyrosine Kinase-like Orphan ReceptorsROR1 protein, humanRNA Splicing Factors

Autor:innen und Institutionen

  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
  • Department of Neurosurgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
  • Beijing Key Laboratory of Drug Innovation For Neuro-Oncology, Beijing, China.

ORCID-Profile: Ruichao Chai

Förderung

  • The Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China
  • High-level Talents Research Start-up Project of the First Affiliated Hospital, Fujian Medical University
  • NSFC/RGC Collaborative Research Scheme
  • Beijing Municipal Health Commission
  • Beijing Key Laboratory of Drug Innovation for Neuro-Oncology
  • Fundings from Beijing Neurosurgical Institute
  • China Postdoctoral Science Foundation

Zitieren

APA

Chen, X., Pang, B., Liu, Y., Wang, J., Zheng, L., Chang, Y., Sun, Y., Sun, H., Chen, H., Cai, J., Wu, Z., Chang, Q., Wang, Y., Kang, D., Jiang, T., & Chai, R. (2026). Targeting WTAP/ROR1/WNT5A‐Mediated Crosstalk Between Glioma Stem Cells and Macrophages to Normalize Tumor Vasculature and Enhance Chemotherapy. Advanced Science, 13(21). https://doi.org/10.1002/advs.202520661

Vancouver

Chen X, Pang B, Liu Y, Wang J, Zheng L, Chang Y, et al. Targeting WTAP/ROR1/WNT5A‐Mediated Crosstalk Between Glioma Stem Cells and Macrophages to Normalize Tumor Vasculature and Enhance Chemotherapy. Advanced Science. 2026;13(21). doi:10.1002/advs.202520661

BibTeX
@article{Chen2026,
  author = {Chen, Xiaoyong and Pang, Bo and Liu, Yun and Wang, Jiangwei and Zheng, Lanhui and Chang, Yuzhou and Sun, Yingxuan and Sun, Haoyuan and Chen, Huiyuan and Cai, Jiawei and Wu, Zanyi and Chang, Qing and Wang, Yongzhi and Kang, Dezhi and Jiang, Tao and Chai, Ruichao},
  title = {Targeting WTAP/ROR1/WNT5A‐Mediated Crosstalk Between Glioma Stem Cells and Macrophages to Normalize Tumor Vasculature and Enhance Chemotherapy},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {21},
  doi = {10.1002/advs.202520661}
}
Kostenlos starten →